TY - JOUR
T1 - Altered microbiota composition reflects enhanced communication in 15q11-13 CNV mice
AU - Septyaningtrias, Dian Eurike
AU - Lin, Chia Wen
AU - Ouchida, Rika
AU - Nakai, Nobuhiro
AU - Suda, Wataru
AU - Hattori, Masahira
AU - Morita, Hidetoshi
AU - Honda, Kenya
AU - Tamada, Kota
AU - Takumi, Toru
N1 - Funding Information:
We thank all technical staff of the Takumi laboratory for their technical assistance. This study was supported by KAKENHI (16H06316, 16H06463) from the Japan Society for the Promotion of Science and Ministry of Education, Culture, Sports, Science, and Technology; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP; the Takeda Science Foundation and Smoking Research Foundation. C-W Lin was supported by The Tokyo Biochemical Research Foundation.
Funding Information:
We thank all technical staff of the Takumi laboratory for their technical assistance. This study was supported by KAKENHI ( 16H06316 , 16H06463 ) from the Japan Society for the Promotion of Science and Ministry of Education, Culture, Sports, Science, and Technology ; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP ; the Takeda Science Foundation and Smoking Research Foundation . C-W Lin was supported by The Tokyo Biochemical Research Foundation . Appendix A
Publisher Copyright:
© 2019 Elsevier B.V. and Japan Neuroscience Society
PY - 2020/12
Y1 - 2020/12
N2 - Autism spectrum disorder (ASD) is a complex and heterogeneous neurodevelopmental disorder. In addition to the core symptoms of ASD, many patients with ASD also show comorbid gut dysbiosis, which may lead to various gastrointestinal (GI) problems. Intriguingly, there is evidence that gut microbiota communicate with the central nervous system to modulate behavioral output through the gut-brain axis. To investigate how the microbiota composition is changed in ASD and to identify which microbes are involved in autistic behaviors, we performed a 16S rRNA gene-based metagenomics analysis in an ASD mouse model. Here, we focused on a model with human 15q11-13 duplication (15q dup), the most frequent chromosomal aberration or copy number variation found in ASD. Species diversity of the microbiome was significantly decreased in 15q dup mice. A combination of antibiotics treatment and behavioral analysis showed that neomycin improved social communication in 15q dup mice. Furthermore, comparison of the microbiota composition of mice treated with different antibiotics enabled us to identify beneficial operational taxonomic units (OTUs) for ultrasonic vocalization.
AB - Autism spectrum disorder (ASD) is a complex and heterogeneous neurodevelopmental disorder. In addition to the core symptoms of ASD, many patients with ASD also show comorbid gut dysbiosis, which may lead to various gastrointestinal (GI) problems. Intriguingly, there is evidence that gut microbiota communicate with the central nervous system to modulate behavioral output through the gut-brain axis. To investigate how the microbiota composition is changed in ASD and to identify which microbes are involved in autistic behaviors, we performed a 16S rRNA gene-based metagenomics analysis in an ASD mouse model. Here, we focused on a model with human 15q11-13 duplication (15q dup), the most frequent chromosomal aberration or copy number variation found in ASD. Species diversity of the microbiome was significantly decreased in 15q dup mice. A combination of antibiotics treatment and behavioral analysis showed that neomycin improved social communication in 15q dup mice. Furthermore, comparison of the microbiota composition of mice treated with different antibiotics enabled us to identify beneficial operational taxonomic units (OTUs) for ultrasonic vocalization.
KW - Autism
KW - Copy number variation
KW - Gut-brain axis
KW - Microbiota
KW - Ultrasonic vocalization
UR - http://www.scopus.com/inward/record.url?scp=85076828919&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076828919&partnerID=8YFLogxK
U2 - 10.1016/j.neures.2019.12.010
DO - 10.1016/j.neures.2019.12.010
M3 - Article
C2 - 31863791
AN - SCOPUS:85076828919
SN - 0168-0102
VL - 161
SP - 59
EP - 67
JO - Neuroscience Research
JF - Neuroscience Research
ER -